Font Size: a A A
Keyword [Heart Failure with Preserved Ejection Fraction]
Result: 21 - 40 | Page: 2 of 9
21. Based On The Study Of Myocardial Cell Calcium Homeostasis, Yiqihuoxue Drugs Prevent And Treat Diastolic Heart Failure
22. The Diagnostic Value Of Plasma BNP And Risk Factors For The Heart Failure With Preserved Ejection Fraction
23. The Diagnostic Value Of Plasma N-Terminal Pro-brain Natriuretic Neptide In The Heart Failure With Preserved Ejection Fraction
24. Effect Of Recombinant Human Brain Natriuretic Peptide On Cardiac Function In Patients With Heart Failure With Preserved Ejection Fraction
25. Clinical Study Of Heart Failure With Preserved Ejection Fraction Treated With Yiqi-yangyin-tongluo Treatment
26. The Protective Mechanism Of Qiliqiangxin By Activating PPAR-Gamma On Cardiac Remodeling
27. Interatrial Dyssynchrony In Heart Failure With Preserved Ejection Fraction Using Two-Dimensional Speckle Tracking Imaging
28. Clinical Study Of Noninvasive Hemodynamic Assessment In Patients With Heart Failure With Preserved Ejection Fraction
29. Correlation Between Monocyte To HDL Cholesterol Ratio And B-type Natriuretic Peptide In Patients With Preserved Ejection Fraction Heart Failure And 2 Type Diabetes Mellitus
30. Efficacy And Safety Of Mineralocorticoid Receptor Antagonists In The Treatment Of Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
31. Vitamin B12 Deficiency In Heart Failure Patients With Preserved Ejection Fraction
32. The Effect Of Spinal Cord Stimulation On Heart Failure With Preserved Ejection Fraction
33. The Value Of Neprilysin In Cardiac Insufficiency With Preserved Ejection Fraction-A Pilot Study
34. Clinical Observation Of Huangqi Baoxin Decoction In The Treatment Of Heart Failure With Preserved Ejection Fraction
35. Clinical Role Of Exhaled Breath Acetone In Patients With Chronic Heart Failure With Preserved Ejection Fraction
36. Serum Concentrations In Heart Failure With Preserved Ejection Fraction(HF-PEF) And The Correlation Analysis With Left Cardiac Function
37. The Study Of MR-proANP In The Diagnostic And Drognostic Value In Patients With Chronic HFpEF
38. The Effect And Mechanism Of ARNi On Myocardial Hypertrophy And Heart Failure With Preserved Ejection Fraction
39. Prevalence, Clinical Characteristics, Outcomes And Risk Factors Of Heart Failure With Preserved Ejection Fraction In Coronary Artery Disease Patients
40. Diagnostic And Prognostic Value Of Left Ventricular Deformation Measurements Derived From Real-Time 3D-STE Combined With Red Cell Distribution Width In HFpEF
  <<First  <Prev  Next>  Last>>  Jump to